Ship Healthcare Holdings, Inc.
2026 Fiscal Year Ending March Earnings Explanation Materials
For the fiscal year ending March 2026, net sales are approximately 71.8 billion yen, an increase of about +2.6% year-over-year. Operating income is approximately 2.45 billion yen, up about +5.8% YoY. Segments such as MSP and PH led revenue growth and profit increase, contributing to overall performance improvement.
Key Figures
- Net sales: 718,163 million yen (YoY +2.6%)
- Operating income: 24,482 million yen (YoY +5.8%)
- Net income: 13,394 million yen (YoY -11.5%)
AI要約
Performance Overview
Ship Healthcare’s fiscal year ending March 2026 results show net sales of approximately 71.8 billion yen (up 2.6% YoY) and operating income of about 2.45 billion yen (up 5.8% YoY). Revenue and profit growth driven by MSP and PH segments, with improved profit margins. The segments maintained steady performance, strengthening the revenue base through expansion in medical logistics and pharmacy chains.
Future Outlook and Investor Impact
The company will continue to pursue growth strategies centered on expanding medical logistics and pharmacy chains. Based on the medium-term management plan, it aims to enhance asset efficiency and profitability. For investors, this indicates a stable earnings base and growth potential, supporting long-term investment value.
Net Sales Trend
Operating Income Trend
Segment Revenue Composition Ratio
Profit Margin Analysis
Ship Healthcare Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
